Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, ASLAN Pharmaceuticals Ltd ADR’s stock clocked out at $0.42, down -7.30% from its previous closing price of $0.45. In other words, the price has decreased by -$7.30 from its previous closing price. On the day, 0.64 million shares were traded. ASLN stock price reached its highest trading level at $0.47 during the session, while it also had its lowest trading level at $0.4113.
Ratios:
To gain a deeper understanding of ASLN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 09, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
On January 14, 2019, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $12 to $8.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASLN now has a Market Capitalization of 9396910 and an Enterprise Value of 240495968. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61. Its current Enterprise Value per Revenue stands at 20.041 whereas that against EBITDA is -5.502.
Stock Price History:
The Beta on a monthly basis for ASLN is 1.52, which has changed by -0.89625 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, ASLN has reached a high of $4.69, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -30.97%, while the 200-Day Moving Average is calculated to be -64.50%.
Shares Statistics:
It appears that ASLN traded 1.21M shares on average per day over the past three months and 1568580 shares per day over the past ten days. A total of 17.60M shares are outstanding, with a floating share count of 16.99M. Insiders hold about 3.48% of the company’s shares, while institutions hold 19.79% stake in the company. Shares short for ASLN as of 1713139200 were 250186 with a Short Ratio of 0.21, compared to 1710460800 on 290509. Therefore, it implies a Short% of Shares Outstanding of 250186 and a Short% of Float of 1.1199999999999999.
Earnings Estimates
The market rating for ASLAN Pharmaceuticals Ltd ADR (ASLN) is a result of the insights provided by 1.0 analysts actively involved in the assessment.On average, analysts expect EPS of -$0.61 for the current quarter, with a high estimate of -$0.61 and a low estimate of -$0.61, while EPS last year was -$1.29. The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.54 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$3.62 and -$3.62 for the fiscal current year, implying an average EPS of -$3.62. EPS for the following year is -$2.42, with 1.0 analysts recommending between -$2.42 and -$2.42.
